ORIGINAL ARTICLE
Year : 2012  |  Volume : 5  |  Issue : 3  |  Page : 327-332

Deliberate hypotension during functional endoscopic sinus surgery ( a comparative study between sodium nitroprusside and dexmedetomidine)


Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Correspondence Address:
Khaled M. Maghawry
MD, Department of Anesthesiology, Intensive Care, and Pain Management, Faculty of Medicine, Ain Shams University, P.O. Box 11331, Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.7123/01.ASJA.0000417542.13591.c9

Rights and Permissions

Background

A randomized, double-blind study was designed to evaluate the efficacy of dexmedetomidine (DEX) as a hypotensive agent in comparison with sodium nitroprusside (SNP) in functional endoscopic sinus surgery (FESS).

Patients and methods

Sixty patients ASA I, aged 18–60 years, scheduled for FESS were randomly assigned to receive either DEX 1 µg/kg over 10 min before induction of anesthesia, followed by an infusion of 0.2–0.6 µg/kg/h during maintenance of anesthesia (DEX group) or an SNP 0.5–10 µg/kg/min infusion after induction of anesthesia (SNP group) to maintain the mean arterial pressure (MAP) between 50 and 65 mmHg. MAP, heart rate, reversibility of hypotensive state, intraoperative blood loss, and requirement of postoperative analgesia were compared between the two groups.

Results

The administration of DEX resulted in a significant reduction in MAP and heart rate at preanesthesia (T1), after induction (T2), and 5 min after stopping the hypotensive agent (T4) in comparison with the SNP group. Intraoperative field conditions were significantly better in the DEX group than in the SNP group at 15, 30, and 45 min after the beginning of the surgery. There was a significant reduction in blood loss in the DEX group than the SNP group. Time for first rescue analgesia was significantly longer in the DEX group than the SNP group.

Conclusion

DEX is an effective and safe agent for controlled hypotension in adults undergoing FESS. It may result in reduced blood loss and a kind of postoperative analgesia.



[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed885    
    Printed33    
    Emailed0    
    PDF Downloaded161    
    Comments [Add]    

Recommend this journal